System Accuracy of BGM GL22
Not Applicable
Completed
- Conditions
- Diabetes
- Registration Number
- NCT06146933
- Lead Sponsor
- Institut fur Diabetes Karlsburg GmbH
- Brief Summary
This study assesses the system accuracy of a blood glucose monitoring system pursuant to ISO 15197
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 113
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Analysis of system accuracy based on DIN EN ISO 15197 Day 1 Assessment of the analytical measurement performance of the blood glucose monitor
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the accuracy of BGM GL22 in diabetes management?
How does BGM GL22 compare to standard-of-care glucose monitoring systems in terms of system accuracy?
Are there specific biomarkers that correlate with improved accuracy of BGM GL22 in diabetic patients?
What adverse events are associated with BGM GL22 use and how are they managed in clinical practice?
What are the key features distinguishing BGM GL22 from other glucose monitoring systems in the market?
Trial Locations
- Locations (1)
Institut für Diabetes Karlsburg GmbH
🇩🇪Karlsburg, Mecklenburg Vorpommern, Germany
Institut für Diabetes Karlsburg GmbH🇩🇪Karlsburg, Mecklenburg Vorpommern, Germany